nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—Naloxone—TLR4—periodontitis	0.11	1	CrCbGaD
Buprenorphine—OPRD1—GPCR ligand binding—ADRB1—periodontitis	0.00203	0.00228	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CXCL3—periodontitis	0.00201	0.00226	CbGpPWpGaD
Buprenorphine—OPRM1—TCR Signaling Pathway—IL1B—periodontitis	0.00201	0.00226	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—IL1A—periodontitis	0.002	0.00225	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—IL10—periodontitis	0.00199	0.00224	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00198	0.00223	CbGpPWpGaD
Buprenorphine—CYP2A6—NRF2 pathway—AGER—periodontitis	0.00198	0.00222	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00197	0.00222	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—CCL2—periodontitis	0.00197	0.00221	CbGpPWpGaD
Buprenorphine—OPRL1—Circadian rythm related genes—IL6—periodontitis	0.00195	0.0022	CbGpPWpGaD
Buprenorphine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—periodontitis	0.00195	0.00219	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—CXCR2—periodontitis	0.00194	0.00218	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—IL4—periodontitis	0.00194	0.00218	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—SLC52A3—periodontitis	0.00186	0.0021	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CXCR2—periodontitis	0.00186	0.00209	CbGpPWpGaD
Buprenorphine—CYP2C8—Arachidonic acid metabolism—PTGS2—periodontitis	0.00186	0.00209	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—CXCL8—periodontitis	0.00186	0.00209	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—MMP3—periodontitis	0.00186	0.00209	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CXCL3—periodontitis	0.00183	0.00206	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—CCR2—periodontitis	0.00179	0.00201	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—ADRB1—periodontitis	0.00178	0.002	CbGpPWpGaD
Buprenorphine—CYP1A2—Phase II conjugation—GGT1—periodontitis	0.00177	0.00199	CbGpPWpGaD
Buprenorphine—ABCB1—HIF-1-alpha transcription factor network—NOS2—periodontitis	0.00176	0.00198	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—CCL2—periodontitis	0.00172	0.00194	CbGpPWpGaD
Buprenorphine—CYP3A5—Biological oxidations—GGT1—periodontitis	0.00172	0.00193	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CXCL3—periodontitis	0.0017	0.00191	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—VIP—periodontitis	0.00166	0.00187	CbGpPWpGaD
Buprenorphine—CYP2C19—Arachidonic acid metabolism—PTGS2—periodontitis	0.00166	0.00187	CbGpPWpGaD
Buprenorphine—OPRM1—TCR Signaling Pathway—TGFB1—periodontitis	0.00156	0.00175	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—CXCL8—periodontitis	0.00155	0.00175	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CXCL3—periodontitis	0.00155	0.00174	CbGpPWpGaD
Buprenorphine—CYP2C9—Arachidonic acid metabolism—PTGS2—periodontitis	0.00151	0.0017	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—CCR2—periodontitis	0.00151	0.0017	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—VIP—periodontitis	0.00151	0.0017	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—ADRB1—periodontitis	0.0015	0.00169	CbGpPWpGaD
Buprenorphine—CYP2C8—Biological oxidations—GGT1—periodontitis	0.00149	0.00167	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—CXCR2—periodontitis	0.00148	0.00166	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—SLC52A3—periodontitis	0.00147	0.00166	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—CCL2—periodontitis	0.00146	0.00164	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—VIP—periodontitis	0.00146	0.00164	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CCR2—periodontitis	0.00145	0.00163	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—periodontitis	0.00144	0.00162	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—ADRB1—periodontitis	0.00144	0.00162	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—periodontitis	0.00138	0.00155	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—CXCL8—periodontitis	0.00136	0.00153	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CXCR2—periodontitis	0.00134	0.00151	CbGpPWpGaD
Buprenorphine—CYP2C19—Biological oxidations—GGT1—periodontitis	0.00133	0.00149	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—VIP—periodontitis	0.00132	0.00149	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00132	0.00148	CbGpPWpGaD
Buprenorphine—OPRD1—G alpha (i) signalling events—CXCL8—periodontitis	0.00131	0.00147	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CXCR2—periodontitis	0.0013	0.00146	CbGpPWpGaD
Buprenorphine—CYP1A2—Arachidonic acid metabolism—PTGS2—periodontitis	0.00129	0.00145	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—periodontitis	0.00129	0.00145	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—SLC52A3—periodontitis	0.00125	0.00141	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—SLC52A3—periodontitis	0.00124	0.00139	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CXCL3—periodontitis	0.00123	0.00139	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—VIP—periodontitis	0.00123	0.00138	CbGpPWpGaD
Buprenorphine—CYP2D6—Biological oxidations—GGT1—periodontitis	0.00122	0.00137	CbGpPWpGaD
Buprenorphine—CYP2C9—Biological oxidations—GGT1—periodontitis	0.00121	0.00136	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—CCL2—periodontitis	0.00121	0.00136	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—NTRK1—periodontitis	0.00118	0.00133	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CXCR2—periodontitis	0.00118	0.00132	CbGpPWpGaD
Buprenorphine—OPRM1—TCR Signaling Pathway—IL6—periodontitis	0.00118	0.00132	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—IFNG—periodontitis	0.00117	0.00132	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00116	0.0013	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—CXCL8—periodontitis	0.00115	0.00129	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—CCR2—periodontitis	0.00115	0.00129	CbGpPWpGaD
Buprenorphine—OPRK1—G alpha (i) signalling events—CXCL8—periodontitis	0.00115	0.00129	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—ADRB1—periodontitis	0.00115	0.00129	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—SLC52A3—periodontitis	0.00114	0.00128	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.00113	0.00127	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—VIP—periodontitis	0.00112	0.00126	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—ACP5—periodontitis	0.0011	0.00124	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CXCR2—periodontitis	0.0011	0.00123	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—MMP3—periodontitis	0.0011	0.00123	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—CXCL8—periodontitis	0.00109	0.00123	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.00108	0.00122	CbGpPWpGaD
Buprenorphine—UGT1A9—NRF2 pathway—TGFB1—periodontitis	0.00108	0.00122	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCL3—periodontitis	0.00108	0.00121	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—CXCL8—periodontitis	0.00105	0.00118	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—IL1B—periodontitis	0.00105	0.00118	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CCR2—periodontitis	0.00105	0.00118	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00104	0.00117	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—ADRB1—periodontitis	0.00104	0.00117	CbGpPWpGaD
Buprenorphine—CYP1A2—Biological oxidations—GGT1—periodontitis	0.00103	0.00116	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CCR2—periodontitis	0.00101	0.00113	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—ADRB1—periodontitis	0.001	0.00113	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—CCL2—periodontitis	0.001	0.00113	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—periodontitis	0.001	0.00112	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CXCR2—periodontitis	0.000996	0.00112	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.000977	0.0011	CbGpPWpGaD
Buprenorphine—OPRM1—G alpha (i) signalling events—CXCL8—periodontitis	0.000971	0.00109	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—CXCL8—periodontitis	0.000954	0.00107	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—periodontitis	0.000934	0.00105	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—periodontitis	0.000934	0.00105	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CCR2—periodontitis	0.000917	0.00103	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.000914	0.00103	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCL3—periodontitis	0.000913	0.00103	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—ADRB1—periodontitis	0.000913	0.00103	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—SLC52A3—periodontitis	0.000896	0.00101	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—VIP—periodontitis	0.000891	0.001	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—CCL2—periodontitis	0.00088	0.000989	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ACP5—periodontitis	0.000869	0.000976	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CCR2—periodontitis	0.000853	0.000959	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—ADRB1—periodontitis	0.000849	0.000955	CbGpPWpGaD
Buprenorphine—CYP2A6—NRF2 pathway—TGFB1—periodontitis	0.000835	0.000939	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—TGFB1—periodontitis	0.000813	0.000913	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—GGT1—periodontitis	0.000798	0.000898	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CXCR2—periodontitis	0.000794	0.000893	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—CXCL8—periodontitis	0.000794	0.000892	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—MMP3—periodontitis	0.000792	0.000891	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—VIP—periodontitis	0.000781	0.000878	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000776	0.000873	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—SLC52A3—periodontitis	0.000776	0.000872	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CCR2—periodontitis	0.000775	0.000871	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.000772	0.000868	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—ADRB1—periodontitis	0.000771	0.000867	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—TNF—periodontitis	0.000759	0.000853	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—CCL2—periodontitis	0.000744	0.000836	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ACP5—periodontitis	0.000737	0.000828	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ACP5—periodontitis	0.00073	0.000821	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CCL2—periodontitis	0.000713	0.000801	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCR2—periodontitis	0.000696	0.000783	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—CXCL8—periodontitis	0.000696	0.000782	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—MMP3—periodontitis	0.000695	0.000781	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—SLC52A3—periodontitis	0.000693	0.000779	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—SLC52A3—periodontitis	0.000676	0.00076	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ACP5—periodontitis	0.00067	0.000753	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—VIP—periodontitis	0.00066	0.000742	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—FGF2—periodontitis	0.000644	0.000724	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—SLC52A3—periodontitis	0.000637	0.000716	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—SLC52A3—periodontitis	0.000632	0.00071	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—PPARA—periodontitis	0.000626	0.000704	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCR2—periodontitis	0.000618	0.000694	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	0.000615	0.000691	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—ADRB1—periodontitis	0.000615	0.000691	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—GGT1—periodontitis	0.000611	0.000687	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCR2—periodontitis	0.000588	0.000661	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—CXCL8—periodontitis	0.000588	0.000661	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—MMP3—periodontitis	0.000587	0.00066	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000571	0.000642	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CXCL8—periodontitis	0.000564	0.000634	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	0.000555	0.000623	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCR2—periodontitis	0.000541	0.000609	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SLC52A3—periodontitis	0.00054	0.000607	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—ADRB1—periodontitis	0.000539	0.000606	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—IL6—periodontitis	0.000536	0.000602	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ACP5—periodontitis	0.000528	0.000594	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CCL2—periodontitis	0.000515	0.000579	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.00051	0.000573	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—MMP9—periodontitis	0.00051	0.000573	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000505	0.000567	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NTRK1—periodontitis	0.000503	0.000566	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GGT1—periodontitis	0.000483	0.000543	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MMP3—periodontitis	0.000468	0.000526	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000465	0.000523	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCR2—periodontitis	0.000458	0.000514	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ACP5—periodontitis	0.000457	0.000514	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ADRB1—periodontitis	0.000456	0.000512	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CCL2—periodontitis	0.000452	0.000508	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—CXCL8—periodontitis	0.000448	0.000504	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NTRK1—periodontitis	0.000441	0.000496	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PPARA—periodontitis	0.000437	0.000492	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TGFB1—periodontitis	0.00042	0.000472	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SLC52A3—periodontitis	0.000417	0.000468	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MMP3—periodontitis	0.00041	0.000461	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GGT1—periodontitis	0.00041	0.000461	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000409	0.00046	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ACP5—periodontitis	0.000408	0.000459	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CXCL8—periodontitis	0.000407	0.000458	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GGT1—periodontitis	0.000406	0.000457	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.000401	0.000451	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ACP5—periodontitis	0.000398	0.000448	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000397	0.000447	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CXCL8—periodontitis	0.000393	0.000442	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CCL2—periodontitis	0.000382	0.000429	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ACP5—periodontitis	0.000375	0.000422	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.000374	0.000421	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NTRK1—periodontitis	0.000373	0.000419	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GGT1—periodontitis	0.000372	0.000419	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ACP5—periodontitis	0.000372	0.000418	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000365	0.00041	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CXCL8—periodontitis	0.000357	0.000401	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MMP3—periodontitis	0.000347	0.00039	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PPARA—periodontitis	0.000346	0.000389	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	0.000339	0.000381	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000333	0.000374	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CXCL8—periodontitis	0.000332	0.000374	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ACP5—periodontitis	0.000318	0.000358	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL6—periodontitis	0.000317	0.000356	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCL2—periodontitis	0.000304	0.000342	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CXCL8—periodontitis	0.000302	0.000339	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GGT1—periodontitis	0.000294	0.00033	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PPARA—periodontitis	0.000293	0.00033	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PPARA—periodontitis	0.000291	0.000327	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTGS2—periodontitis	0.000284	0.00032	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000284	0.00032	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—FGF2—periodontitis	0.000275	0.000309	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCL2—periodontitis	0.000267	0.0003	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PPARA—periodontitis	0.000267	0.0003	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000266	0.000299	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GGT1—periodontitis	0.000254	0.000286	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ACP5—periodontitis	0.000245	0.000276	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—FGF2—periodontitis	0.000241	0.000271	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CXCL8—periodontitis	0.000241	0.00027	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000237	0.000267	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL6—periodontitis	0.000229	0.000257	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GGT1—periodontitis	0.000227	0.000255	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCL2—periodontitis	0.000226	0.000253	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTGS2—periodontitis	0.000225	0.000253	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GGT1—periodontitis	0.000222	0.000249	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MMP9—periodontitis	0.000218	0.000245	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000216	0.000243	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCL8—periodontitis	0.000211	0.000237	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PPARA—periodontitis	0.00021	0.000236	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GGT1—periodontitis	0.000209	0.000235	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GGT1—periodontitis	0.000207	0.000233	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—FGF2—periodontitis	0.000204	0.000229	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL6—periodontitis	0.000201	0.000225	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MMP9—periodontitis	0.000191	0.000214	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTGS2—periodontitis	0.000191	0.000214	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTGS2—periodontitis	0.000189	0.000213	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000185	0.000208	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PPARA—periodontitis	0.000182	0.000205	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TGFB1—periodontitis	0.000179	0.000202	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCL8—periodontitis	0.000178	0.0002	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GGT1—periodontitis	0.000177	0.000199	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGS2—periodontitis	0.000173	0.000195	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6—periodontitis	0.00017	0.000191	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PPARA—periodontitis	0.000163	0.000183	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MMP9—periodontitis	0.000161	0.000181	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PPARA—periodontitis	0.000159	0.000178	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TGFB1—periodontitis	0.000157	0.000177	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PPARA—periodontitis	0.000149	0.000168	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PPARA—periodontitis	0.000148	0.000167	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGS2—periodontitis	0.000137	0.000154	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GGT1—periodontitis	0.000137	0.000153	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6—periodontitis	0.000135	0.000152	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TGFB1—periodontitis	0.000133	0.000149	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PPARA—periodontitis	0.000127	0.000142	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6—periodontitis	0.000119	0.000133	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS2—periodontitis	0.000118	0.000133	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS2—periodontitis	0.000106	0.000119	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS2—periodontitis	0.000103	0.000116	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6—periodontitis	0.0001	0.000113	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PPARA—periodontitis	9.77e-05	0.00011	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS2—periodontitis	9.72e-05	0.000109	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS2—periodontitis	9.64e-05	0.000108	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS2—periodontitis	8.23e-05	9.25e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS2—periodontitis	6.35e-05	7.14e-05	CbGpPWpGaD
